Seshu Tyagarajan, Chief Technology Officer at Candel Therapeutics, Inc. (CADL), sold 28,644 shares at $7.23 ($207K) on 2025-01-15, disclosed to the SEC on 2025-01-17.
Open-market sale of $207k CADL by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.23 | 14,322 | $104K | 50.0% |
| 2 | $7.23 | 14,322 | $104K | 50.0% |
| Total | $7.23 avg | 28,644 | $207K | 100% |
| Filing → |
| CADL | SELL | 2025-03-20 | $552K | — | Filing → |
| CADL | SELL | 2025-01-10 | $239K | — | Filing → |
| CADL | SELL | 2024-12-03 | $186K | — | Filing → |